Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 29
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Allosteric binding cooperativity in a kinetic context

  • Díaz Sanzo, Óscar|||0000-0002-8374-1693
  • Martín, Victor
  • Renault de Barros, Pedro Victor|||0000-0002-5649-3057
  • Romero i Sànchez, David|||0000-0002-2881-268X
  • Guillamon, Antoni|||0000-0001-8268-4503
  • Giraldo, Jesús|||0000-0001-7082-4695
Allosteric modulators are of prime interest in drug discovery. These drugs regulate the binding and function of endogenous ligands, with some advantages over orthosteric ligands. A typical pharmacological parameter in allosteric modulation is binding cooperativity. This property can yield unexpected but illuminating results when decomposed into its kinetic parameters. Using two reference models (the allosteric ternary complex receptor model and a heterodimer receptor model), a relationship has been derived for the cooperativity rate constant parameters. This relationship allows many combinations of the cooperativity kinetic parameters for a single binding cooperativity value obtained under equilibrium conditions. This assessment may help understand striking experimental results involving allosteric modulation and suggest further investigations in the field.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A mathematical formalism to quantify drug-target residence time

  • Ortiz, Antonio J.
  • Romero i Sànchez, David|||0000-0002-2881-268X
  • Guillamon, Antoni|||0000-0001-8268-4503
  • Giraldo, Jesús|||0000-0001-7082-4695
Despite drug-target residence time (RT) is a key topic in binding kinetics, little information exists on its theoretical quantification. The two most frequent mathematical expressions found in the literature correspond to two particular and simple pharmacological cases: the binary ligand-receptor complex and the induction-fit model. In this article, we propose a mathematical formalism to obtain an expression of RT that can be of general applicability. RT is calculated from the system of ordinary differential equations (ODE) obtained by applying the Law of Mass Action to the selected chemical process. Then, a subsystem is constructed by defining which chemical species are of interest and omitting their global formation processes. RT maintains its accepted definition of 1/koff, where koff is here defined as the absolute value of the smallest-modulus eigenvalue of the subsystem. The proposed procedure is successfully used to derive RT for a wide variety of pharmacological cases. In particular, the theoretical expressions of RT obtained for binary ligand-receptor binding and induction-fit coincide with those previously found in the literature. An extension of the RT pharmacological framework is proposed by including the concept of relaxation time (RXT), which involves pharmacological conditions associated with receptor activation rather than receptor binding. To conclude, the herein presented formalism for RT and RXT provides a mathematical framework that can be of general applicability in many pharmacological systems. It is expected that the procedure may be helpful in different pharmacological areas such as binding kinetics, PK/PD and enzymology.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

miRNA signatures associated with vulnerability to food addiction in mice and humans

  • García Blanco, Alejandra
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernández-Castillo, Noèlia
  • Pineda-Cirera, Laura
  • Mayneris Perxachs, Jordi
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
Food addiction is characterized by a loss of behavioral control over food intake and is associated with obesity and other eating disorders. The mechanisms underlying this behavioral disorder are largely unknown. We aimed to investigate the changes in miRNA expression promoted by food addiction in animals and humans and their involvement in the mechanisms underlying the behavioral hallmarks of this disorder. We found sharp similitudes between miRNA signatures in the medial prefrontal cortex (mPFC) of our animal cohort and circulating miRNA levels in our human cohort, which allowed us to identify several miRNAs of potential interest in the development of this disorder. Tough decoy (TuD) inhibition of miRNA-29c-3p in the mouse mPFC promoted persistence of the response and enhanced vulnerability to developing food addiction, whereas miRNA-665-3p inhibition promoted compulsion-like behavior and also enhanced food addiction vulnerability. In contrast, we found that miRNA-137-3p inhibition in the mPFC did not lead to the development of food addiction. Therefore, miRNA-29c-3p and miRNA-665-3p could be acting as protective factors with regard to food addiction. We believe the elucidation of these epigenetic mechanisms will lead to advances toward identifying innovative biomarkers and possible future interventions for food addiction and related disorders based on the strategies now available to modify miRNA activity and expression., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to RM; SAF2015-68341-R, RTI2018-100968-B-100, and PID2021-1277760B-100, to BC; and SAF2017-84060-R-AEI/FEDER-UE, to LD); the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to RM; 2017 SGR-734, to JMFR; 2017-SGR-738, to BC); the “ICREA-Acadèmia” (2020, to RM, 2021, to BC, and 2022, to JMFR); the “European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068, to RM; CoCA, H2020-667302, and Eat2beNICE, H2020-728018, to BC); the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020, to RM; FIS PI15/01934, PI18/01022, PI21/01361, to JMFR); the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to RM; PNSD-2019I006, to EMG; PNSD-2017I050, to BC; PNSD-2020I042, to NFC); the “Fundació La Marató-TV3” (2016/20-30, to EMG); the European Regional Development Fund (project no. 01.2.2-LMT-K-718-03-0099) under a grant agreement with the Research Council of Lithuania (LMTLT), to AB; and the Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Role of CB2 cannabinoid receptor in the development of food addiction in male mice

  • García Blanco, Alejandra
  • Ramírez López, Ángela, 1992-
  • García-Gutiérrez, María S.
  • Manzanares, Jorge
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
The endocannabinoid system plays an important role in multiple behavioral responses due to its wide distribution in the central nervous system. The cannabinoid CB1 receptor was associated to the loss of behavioral control over food intake occurring during food addiction. The cannabinoid CB2 receptor (CB2R) is expressed in brain areas canonically associated with addictive-like behavior and was linked to drug-addictive properties. In this study, we evaluated for the first time the specific role of the CB2R in food addiction by using a well-validated operant mouse model of long-term training to obtain highly palatable food. We have compared in this model the behavioral responses of wild-type mice, mutant mice constitutively lacking CB2R, and transgenic mice overexpressing CB2R. The lack of CB2R constitutes a protective factor for the development of food addiction and the impulsive and depressive-like behavior associated. In contrast, the overexpression of CB2R induces a vulnerable phenotype toward food addiction after long-term exposure to highly palatable chocolate pellets. Relevant transcriptomic changes were associated to resilience and vulnerability to food addiction depending on the genotype, which provides a mechanistic explanation for these behavioral changes. Therefore, CB2R may constitute a potential therapeutic target for the loss of eating control and the comorbid emotional effects associated to food addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to RM; the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to RM; the “ICREA-Acadèmia” (2020) to RM; the “European Commission-DG Research” (PainFact, H2020-SC1–2019-2-RTD-848099, QSPain Relief, H2020-SC1–2019-2-RTD-848068) to RM; the Spanish”la Caixa” Foundation under the project code LCF/PR/HR22/52420017 to R.M., the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM; the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to RM; PNSD- 2019I006, to EMG; Ministerio de Ciencia e Innovación (ERA-NET) PCI2021–122073-2A to EMG; and “Instituto de Salud Carlos III”, Spanish “Ministerio de Ciencia e Innovación” (RD21/0009/0008, “Red de Investigación en Atención Primaria de Adicciones”) to JM.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model

  • Cajiao-Manrique, María Del Mar
  • Casadó-Anguera, Verònica
  • García Blanco, Alejandra
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Background: Cannabis addiction is a chronically relapsing disorder lacking effective treatment. Regular cannabis consumption typically begins during adolescence, and this early cannabinoid exposure may increase the risk for drug addiction in adulthood. Objective: This study investigates the development of cannabis addiction-like behavior in adult mice after adolescent exposure to the main psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC). Methods: Adolescent male mice were exposed to 5 mg/kg of THC from postnatal days 37 to 57. Operant self-administration sessions of WIN 55,212-2 (12.5 μg/kg/infusion) were conducted for 10 days. Mice were tested for three addiction-like criteria (persistence of response, motivation, and compulsivity), two parameters related to craving (resistance to extinction and drug-seeking behavior), and two phenotypic vulnerability traits related to substance use disorders (impulsivity and reward sensitivity). Additionally, qPCR assays were performed to detect differentially expressed genes in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), dorsal striatum, and hippocampus (HPC) of "addicted" and "non-addicted" mice. Results: Adolescent THC exposure did not modify WIN 55,212-2 reinforcement nor the development of cannabis addiction-like behavior. Inversely, THC pre-exposed mice displayed impulsive-like behavior in adulthood, which was more pronounced in mice that developed the addiction-like criteria. Moreover, downregulated drd2 and adora2a gene expression in NAc and HPC was revealed in THC pre-exposed mice, as well as a downregulation of drd2 expression in mPFC of vehicle pre-treated mice that developed addiction-like behaviors. Discussion: These findings suggest that adolescent THC exposure may promote impulsivity-like behavior in adulthood, associated with downregulated drd2 and adora2a expression in NAc and HPC., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, R D21/0009/0019) to RM, the “Generalitat de Catalunya, AGAUR” (2017 SGR-669) to RM, the “ICREA-Acadèmia” (2020) to RM, the “European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099 and QSPain Relief, H2020-SC1-2019-2-RTD-848068) to RM, the Spanish “La Caixa” Foundation under the project code LCF/PR/HR22/52420017 to RM, the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM, the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD-2021I076 to RM and PNSD-2019I006 to EM-G), and Ministerio de Ciencia e Innovación (ERA-NET NEURON) PCI2021-122073-2A to EM-G. MC-M acknowledged the Generalitat de Catalunya and the AGAUR for a “FI-SDUR” scholarship (EMC/3345/2020). AG-B acknowledged the Generalitat de Catalunya and the AGAUR for the “FI” scholarship (FI_B00337_2020). VC-A acknowledged the Spanish MCIN/AEI/10.13039/501100011033 for a “Juan de la Cierva” fellowship (FJC2019-041020-I).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Presence of blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Clàudia
  • Zapata-Tona, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió-Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona, Reinald
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor's Blastocystis subtypes led to altered recipient's mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Operant self-medication for assessment of spontaneous pain relief and drug abuse liability in mouse models of chronic pain

  • Cabañero Ferri, David
  • Álvarez-Pérez, Beltrán
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
The search for safe and efficient chronic pain treatments is dampened by the lack of reliable models that faithfully reproduce current pharmacological treatments for chronic spontaneous pain in humans. Preclinical models often assess the antinociceptive efficacy of non-contingent pharmacological treatments evaluated in the short-term. Here, we provide a protocol of contingent operant self-medication in mice, which allows the estimation of spontaneous pain relief and drug abuse liability in models of persistent pain. This paradigm requires preliminary habituation and animal handling, followed by training of mice in operant conditioning boxes, to allow subsequent analgesic drug self-administration. After the initial acquisition of food-maintained operant behavior, a chronic pain sensitization is induced. Posterior intravenous jugular catheterization and coupling of operant conditioning boxes to perfusion pumps allow quantification of operant responding for intravenous drug self-administration. All mice show an initial operant drug self-administration behavior associated with the previous food-maintained operant training. This initial operant responding is extinguished after administration of ineffective treatments, but continues when the compounds have analgesic efficacy or intrinsic reinforcing properties. The identification of a significant drug self-administration selectively expressed in mice exposed to the chronic pain condition is indicative of analgesic drug effects, whereas persistent self-administration in control mice is indicative of abuse liability. The present protocol provides the behavioral and surgical procedures needed to assess spontaneous pain relief and potential for abuse of pharmacological treatments, through contingent analgesic self-medication in mice., This work was supported by the European Comission [NeuroPain, FP7-602891-2], the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848068 [QSPainRelief, H2020-SC1-2019-2-RTD-848068], the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R- AEI/FEDER-UE), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023), the Generalitat de Catalunya, AGAUR (#2017 SGR-669), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas (#PNSD- 2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) and Plan Nacional Sobre Drogas of the Spanish Ministry of Health (#PNSD-2019I006) to E.M-G. The methodology described was previously used in Bura et al. (2013, 2018) and Cabañero et al. (2020, doi: 10.7554/eLife.55582). Authors also want to thank E. Senabre and R. Martín for their critics and technical support.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A male mouse model of WIN 55,212-2 self-administration to study cannabinoid addiction

  • Cajiao-Manrique, María Del Mar
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
We have established for the first time a mouse model of cannabinoid addiction using WIN 55,212-2 intravenous self-administration (0.0125 mg/kg/infusion) in C57Bl/6J mice. This model allows to evaluate the addiction criteria by grouping them into 1) persistence of response during a period of non-availability of the drug, 2) motivation for WIN 55,212-2 with a progressive ratio, and 3) compulsivity when the reward is associated with a punishment such as an electric foot-shock, in agreement with the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5). This model also allows to measure two parameters that have been related with the DSM-5 diagnostic criteria of craving, resistance to extinction and reinstatement, and two phenotypic traits suggested as predisposing factors, impulsivity and sensitivity to reward. We found that 35.6% of mice developed the criteria of cannabinoid addiction, allowing to differentiate between resilient and vulnerable mice. Therefore, we have established a novel and reliable model to study the neurobiological correlates underlying the resilience or vulnerability to develop cannabinoid addiction. This model included the chemogenetic inhibition of neuronal activity in the medial prefrontal cortex to the nucleus accumbens pathway to assess the neurobiological substrate of cannabinoid addiction. This model will shed light on the neurobiological substrate underlying cannabinoid addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to MR; the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to MR; the “ICREA-Acadèmia” (2020) to MR; the “European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068) to MR; the Spanish ”la Caixa” Foundation under the project code LCF/PR/HR22/52420017 to MR, the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to MR; the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to MR; PNSD- 2019I006, to ME) and Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to ME.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Microviridae bacteriophages influence behavioural hallmarks of food addiction via tryptophan and tyrosine signalling pathways

  • Castells-Nobau, Anna
  • Puig, Irene
  • Motger-Albertí, Anna
  • Vega-Correa, Lisset de la
  • Rosell-Díaz, Marisel
  • Arnoriaga-Rodríguez, María
  • Escrichs, Anira
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Ramió-Torrentà, Lluís
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Pamplona, Reinald
  • Jové, Mariona
  • Sol, Joaquim
  • Martin-Garcia, Elena
  • Martinez-Garcia, Manuel
  • Deco, Gustavo
  • Maldonado-Lopez, Rafael
  • Fernández-Real, José-Manuel
  • Mayneris-Perxachs, Jordi
  • Martinez-Garcia, Manuel|||/items/8fc0773c-5327-46a0-9cda-e5d2ac19bc69
Food addiction contributes to the obesity pandemic, but the connection between how the gut microbiome is linked to food addiction remains largely unclear. Here we show that Microviridae bacteriophages, particularly Gokushovirus WZ-2015a, are associated with food addiction and obesity across multiple human cohorts. Further analyses reveal that food addiction and Gokushovirus are linked to serotonin and dopamine metabolism. Mice receiving faecal microbiota and viral transplantation from human donors with the highest Gokushovirus load exhibit increased food addiction along with changes in tryptophan, serotonin and dopamine metabolism in different regions of the brain, together with alterations in dopamine receptors. Mechanistically, targeted tryptophan analysis shows lower anthranilic acid (AA) concentrations associated with Gokushovirus. AA supplementation in mice decreases food addiction and alters pathways related to the cycle of neurotransmitter synthesis release. In Drosophila, AA regulates feeding behaviour and addiction-like ethanol preference. In summary, this study proposes that bacteriophages in the gut microbiome contribute to regulating food addiction by modulating tryptophan and tyrosine metabolism.
Repositori Obert UdL
Publication Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Claudia
  • Zapata, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové Font, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris-Perxachs, Jordi
  • Arnoriaga-Rodríguez, María
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Clàudia
  • Zapata-Tona, Cristina
  • Pedraza, Salvador
  • Pérez-Brocal, Vicente
  • Ramió-Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové, Mariona
  • Sol, Joaquim
  • Portero-Otín, Manuel
  • Pamplona, Reinald
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Role of CB2 cannabinoid receptor in the development of food addiction in male mice

  • García-Blanco, Alejandra
  • Ramírez-López, Á.
  • Navarrete, Francisco
  • García-Gutiérrez, María Salud
  • Manzanares, Jorge
  • Martín-García, Elena
  • Maldonado, Rafael
The endocannabinoid system plays an important role in multiple behavioral responses due to its wide distribution in the central nervous system. The cannabinoid CB1 receptor was associated to the loss of behavioral control over food intake occurring during food addiction. The cannabinoid CB2 receptor (CB2R) is expressed in brain areas canonically associated with addictive-like behavior and was linked to drug-addictive properties. In this study, we evaluated for the first time the specific role of the CB2R in food addiction by using a well-validated operant mouse model of long-term training to obtain highly palatable food. We have compared in this model the behavioral responses of wild-type mice, mutant mice constitutively lacking CB2R, and transgenic mice overexpressing CB2R. The lack of CB2R constitutes a protective factor for the development of food addiction and the impulsive and depressive-like behavior associated. In contrast, the overexpression of CB2R induces a vulnerable phenotype toward food addiction after long-term exposure to highly palatable chocolate pellets. Relevant transcriptomic changes were associated to resilience and vulnerability to food addiction depending on the genotype, which provides a mechanistic explanation for these behavioral changes. Therefore, CB2R may constitute a potential therapeutic target for the loss of eating control and the comorbid emotional effects associated to food addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to RM; the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to RM; the “ICREA-Acadèmia” (2020) to RM; the “European Commission-DG Research” (PainFact, H2020-SC1–2019-2-RTD-848099, QSPain Relief, H2020-SC1–2019-2-RTD-848068) to RM; the Spanish”la Caixa” Foundation under the project code LCF/PR/HR22/52420017 to R.M., the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM; the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to RM; PNSD- 2019I006, to EMG; Ministerio de Ciencia e Innovación (ERA-NET) PCI2021–122073-2A to EMG; and “Instituto de Salud Carlos III”, Spanish “Ministerio de Ciencia e Innovación” (RD21/0009/0008, “Red de Investigación en Atención Primaria de Adicciones”) to JM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Microviridae bacteriophages influence behavioural hallmarks of food addiction via tryptophan and tyrosine signalling pathways

  • Castells-Nobau, Anna
  • Puig, Irene
  • Motger-Albertí, Anna
  • Vega-Correa, Lisset de la
  • Rosell-Díaz, Marisel
  • Arnoriaga-Rodríguez, María
  • Escrichs, Anira
  • Garre-Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Ramió-Torrentà, Lluís
  • Pérez-Brocal, Vicente
  • Moya, Andrés
  • Pamplona, Reinald
  • Jové, Mariona
  • Sol, Joaquim
  • Martin-Garcia, Elena
  • Martínez-García, Manuel
  • Deco, Gustavo
  • Maldonado, Rafael
  • Fernández-Real, José Manuel
  • Mayneris-Perxachs, Jordi
The raw metagenomics sequence data derived from human samples in the IRONMET-CGM, IRONMET, Aging Imageomics and Health Imageomics cohorts have been deposited in the European Nucleotide Archive under project numbers PRJEB58106, PRJEB39631, PRJEB52682 and PRJEB61680, respectively. The raw metagenomics sequence data from the second FMT experiment have also been deposited in the European Nucleotide Archive under project number PRJEB39631., Food addiction contributes to the obesity pandemic, but the connection between how the gut microbiome is linked to food addiction remains largely unclear. Here we show that Microviridae bacteriophages, particularly Gokushovirus WZ-2015a, are associated with food addiction and obesity across multiple human cohorts. Further analyses reveal that food addiction and Gokushovirus are linked to serotonin and dopamine metabolism. Mice receiving faecal microbiota and viral transplantation from human donors with the highest Gokushovirus load exhibit increased food addiction along with changes in tryptophan, serotonin and dopamine metabolism in different regions of the brain, together with alterations in dopamine receptors. Mechanistically, targeted tryptophan analysis shows lower anthranilic acid (AA) concentrations associated with Gokushovirus. AA supplementation in mice decreases food addiction and alters pathways related to the cycle of neurotransmitter synthesis release. In Drosophila, AA regulates feeding behaviour and addiction-like ethanol preference. In summary, this study proposes that bacteriophages in the gut microbiome contribute to regulating food addiction by modulating tryptophan and tyrosine metabolism., This work was partially funded by Instituto de Salud Carlos III (ISCIII, Madrid, Spain) through the project PI15/01934 to J.M.F.-R. and the projects PI20/01090 and PI23/00575 (co-funded by the European Union under the European Regional Development Fund (FEDER) ‘A way to make Europe’) to J.M.-P. (HR22-00737). The Aging Imageomics Study was funded by Pla estratègic de recerca i innovació en salut 2016–2020 from Generalitat de Catalunya (reference no. SLT002/16/00250). Health Imageomics was funded by Health LivingLab operation of the Girona Healthy Region Program, which was granted by the Projectes d’Especialització i Competitivitat Territorial of the RIS3Cat and the Operative Programme of the European Regional Development Fund of Catalonia 2014–2020. This work was also supported by the Spanish ‘Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación’ (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to R.M.; the ‘Generalitat de Catalunya, AGAUR’ (2017 SGR-669, to R.M.; the ‘ICREA-Acadèmia’ (2020, to R.M.); the ‘European Commission-DG Research’ (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068, to R.M.); the Spanish ‘la Caixa’ Foundation under project code LCF/PR/HR22/52420017 to R.M. and J.M.F.-R.; the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (RD16/0017/0020, to R.M.); the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas’ (PNSD-2021I076, to R.M.; PNSD-2023I040, to E.M.G.; and Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to E.M.G. This study has been co-financed by FEDER funds from the European Union (‘A way to build Europe’) and the Generalitat of Catalonia: Agency for Management of University and Research Grants (2021SGR00990) and Department of Health (SLT002/16/00250) to R.P. IDIBGI is a CERCA Programme/Generalitat de Catalunya. J.M.-P. and A.C.N. are funded by Instituto de Salud Carlos III (Madrid, Spain) through the Miguel Servet Program CP18/00009 and Sara Borrell Program CD20/00051 (co-funded by the European Union under the European Social Fund ‘Investing in Your Future’), respectively. L.V.-C. is funded by the Program for the Promotion of Talent and Employability (Generalitat de Catalunya) SLT017_20_000164. This study was conducted using samples and/or data from the Aging Imageomics Study, supported by the Generalitat de Catalunya through the Strategic Plan for Health Research and Innovation 2016–2020 (SLT002/16/00250). We particularly acknowledge the participants of the IDIBGI Horizontal Aging Program and the IDIBGI Biobank (Biobanc IDIBGI, B.0000872), integrated in the Platform ISCIII Biomodels and Biobanks, for their collaboration. This study was conducted using samples and/or data from the Healthy Imageomics Study, supported by the Specialization and Territorial Competitiveness Projects within the RIS3Cat and the Catalonia European Regional Development Fund (ERDF) Operational Programme 2014–2020. It was co-financed by the ERDF of the European Union under the Catalonia ERDF Operational Programme 2014–2020 and by the Diputació de Girona. Illustrations were created with Biorender.com., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Time-dependent ligand-receptor binding kinetics and functionality in a heterodimeric receptor model

  • Ortiz García, José Antonio
  • Ortega, Víctor Martín
  • Romero Sánchez, David
  • Guillamon Grabolosa, Antoni|||0000-0001-8268-4503
  • Giraldo Arjonilla, Jesús
GPCRs heteromerize both in CNS and non-CNS regions. The cell uses receptor heteromerization to modulate receptor functionality and to provide fine tuning of receptor signaling. In order for pharmacologists to explore these mechanisms for therapeutic purposes, quantitative receptor models are needed. We have developed a timedependent model of the binding kinetics and functionality of a preformed heterodimeric receptor involving two drugs. Two cases were considered: both or only one of the drugs are in excess with respect to the total concentration of the receptor. The latter case can be applied to those situations in which a drug causes unwanted side effects that need to be reduced by decreasing its concentration. The required efficacy can be maintained by the allosteric effects mutually exerted by the two drugs in the two-drug combination system. We discuss this concept assuming that the drug causing unwanted side effects is an opioid and that analgesia is the therapeutic effect. As additional points, allosteric modulation by endogenous compounds and synthetic bivalent ligands was included in the study. Receptor heteromerization offers a mechanistic understanding and quantification of the pharmacological effects elicited by combinations of two drugs at different doses and with different efficacies and cooperativity effects, thus providing a conceptual framework for drug combination therapy., This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 848068. This publication reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains. This work is partially supported by the grants PID2020-119136RB-I00, PID-2021-122954NB-I00, PID2022-137708NB-I00 and the Severo Ochoa and María de Maeztu Programs for Centers and Units of Excellence in R&D (CEX2020-001084-M) funded by MCIN/AEI/10.13039/501100011033 and by ERDF “A way of making Europe”, and by the AGAUR grant 2021-SGR-01039. AJO is funded by FPI fellowship (PRE2021-100772) associated to PID2020-119136RB-I00 grant., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A male mouse model of WIN 55,212-2 self-administration to study cannabinoid addiction

  • Cajiao-Manrique, María Del Mar
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
We have established for the first time a mouse model of cannabinoid addiction using WIN 55,212-2 intravenous self-administration (0.0125 mg/kg/infusion) in C57Bl/6J mice. This model allows to evaluate the addiction criteria by grouping them into 1) persistence of response during a period of non-availability of the drug, 2) motivation for WIN 55,212-2 with a progressive ratio, and 3) compulsivity when the reward is associated with a punishment such as an electric foot-shock, in agreement with the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5). This model also allows to measure two parameters that have been related with the DSM-5 diagnostic criteria of craving, resistance to extinction and reinstatement, and two phenotypic traits suggested as predisposing factors, impulsivity and sensitivity to reward. We found that 35.6% of mice developed the criteria of cannabinoid addiction, allowing to differentiate between resilient and vulnerable mice. Therefore, we have established a novel and reliable model to study the neurobiological correlates underlying the resilience or vulnerability to develop cannabinoid addiction. This model included the chemogenetic inhibition of neuronal activity in the medial prefrontal cortex to the nucleus accumbens pathway to assess the neurobiological substrate of cannabinoid addiction. This model will shed light on the neurobiological substrate underlying cannabinoid addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to MR; the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to MR; the “ICREA-Acadèmia” (2020) to MR; the “European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068) to MR; the Spanish ”la Caixa” Foundation under the project code LCF/PR/HR22/52420017 to MR, the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to MR; the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to MR; PNSD- 2019I006, to ME) and Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to ME.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Operant self-medication for assessment of spontaneous pain relief and drug abuse liability in mouse models of chronic pain

  • Cabañero Ferri, David
  • Álvarez-Pérez, Beltrán
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
The search for safe and efficient chronic pain treatments is dampened by the lack of reliable models that faithfully reproduce current pharmacological treatments for chronic spontaneous pain in humans. Preclinical models often assess the antinociceptive efficacy of non-contingent pharmacological treatments evaluated in the short-term. Here, we provide a protocol of contingent operant self-medication in mice, which allows the estimation of spontaneous pain relief and drug abuse liability in models of persistent pain. This paradigm requires preliminary habituation and animal handling, followed by training of mice in operant conditioning boxes, to allow subsequent analgesic drug self-administration. After the initial acquisition of food-maintained operant behavior, a chronic pain sensitization is induced. Posterior intravenous jugular catheterization and coupling of operant conditioning boxes to perfusion pumps allow quantification of operant responding for intravenous drug self-administration. All mice show an initial operant drug self-administration behavior associated with the previous food-maintained operant training. This initial operant responding is extinguished after administration of ineffective treatments, but continues when the compounds have analgesic efficacy or intrinsic reinforcing properties. The identification of a significant drug self-administration selectively expressed in mice exposed to the chronic pain condition is indicative of analgesic drug effects, whereas persistent self-administration in control mice is indicative of abuse liability. The present protocol provides the behavioral and surgical procedures needed to assess spontaneous pain relief and potential for abuse of pharmacological treatments, through contingent analgesic self-medication in mice., This work was supported by the European Comission [NeuroPain, FP7-602891-2], the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848068 [QSPainRelief, H2020-SC1-2019-2-RTD-848068], the Spanish Ministerio de Economía y Competitividad-MINECO (#SAF2017-84060-R- AEI/FEDER-UE), the Spanish Instituto de Salud Carlos III, RETICS-RTA (#RD12/0028/0023), the Generalitat de Catalunya, AGAUR (#2017 SGR-669), ICREA-Acadèmia (#2015) and the Spanish Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas (#PNSD- 2017I068) to R.M., Fundació La Marató-TV3 (#2016/20-30) and Plan Nacional Sobre Drogas of the Spanish Ministry of Health (#PNSD-2019I006) to E.M-G. The methodology described was previously used in Bura et al. (2013, 2018) and Cabañero et al. (2020, doi: 10.7554/eLife.55582). Authors also want to thank E. Senabre and R. Martín for their critics and technical support.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Role of CB2 cannabinoid receptor in the development of food addiction in male mice

  • García Blanco, Alejandra
  • Ramírez López, Ángela, 1992-
  • García-Gutiérrez, María S.
  • Manzanares, Jorge
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
The endocannabinoid system plays an important role in multiple behavioral responses due to its wide distribution in the central nervous system. The cannabinoid CB1 receptor was associated to the loss of behavioral control over food intake occurring during food addiction. The cannabinoid CB2 receptor (CB2R) is expressed in brain areas canonically associated with addictive-like behavior and was linked to drug-addictive properties. In this study, we evaluated for the first time the specific role of the CB2R in food addiction by using a well-validated operant mouse model of long-term training to obtain highly palatable food. We have compared in this model the behavioral responses of wild-type mice, mutant mice constitutively lacking CB2R, and transgenic mice overexpressing CB2R. The lack of CB2R constitutes a protective factor for the development of food addiction and the impulsive and depressive-like behavior associated. In contrast, the overexpression of CB2R induces a vulnerable phenotype toward food addiction after long-term exposure to highly palatable chocolate pellets. Relevant transcriptomic changes were associated to resilience and vulnerability to food addiction depending on the genotype, which provides a mechanistic explanation for these behavioral changes. Therefore, CB2R may constitute a potential therapeutic target for the loss of eating control and the comorbid emotional effects associated to food addiction., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to RM; the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to RM; the “ICREA-Acadèmia” (2020) to RM; the “European Commission-DG Research” (PainFact, H2020-SC1–2019-2-RTD-848099, QSPain Relief, H2020-SC1–2019-2-RTD-848068) to RM; the Spanish”la Caixa” Foundation under the project code LCF/PR/HR22/52420017 to R.M., the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM; the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to RM; PNSD- 2019I006, to EMG; Ministerio de Ciencia e Innovación (ERA-NET) PCI2021–122073-2A to EMG; and “Instituto de Salud Carlos III”, Spanish “Ministerio de Ciencia e Innovación” (RD21/0009/0008, “Red de Investigación en Atención Primaria de Adicciones”) to JM.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Time-dependent ligand-receptor binding kinetics and functionality in a heterodimeric receptor model

  • Ortiz García, José Antonio
  • Ortega, Víctor Martín
  • Romero Sánchez, David
  • Guillamon Grabolosa, Antoni
  • Giraldo Arjonilla, Jesús
GPCRs heteromerize both in CNS and non-CNS regions. The cell uses receptor heteromerization to modulate receptor functionality and to provide fine tuning of receptor signaling. In order for pharmacologists to explore these mechanisms for therapeutic purposes, quantitative receptor models are needed. We have developed a timedependent model of the binding kinetics and functionality of a preformed heterodimeric receptor involving two drugs. Two cases were considered: both or only one of the drugs are in excess with respect to the total concentration of the receptor. The latter case can be applied to those situations in which a drug causes unwanted side effects that need to be reduced by decreasing its concentration. The required efficacy can be maintained by the allosteric effects mutually exerted by the two drugs in the two-drug combination system. We discuss this concept assuming that the drug causing unwanted side effects is an opioid and that analgesia is the therapeutic effect. As additional points, allosteric modulation by endogenous compounds and synthetic bivalent ligands was included in the study. Receptor heteromerization offers a mechanistic understanding and quantification of the pharmacological effects elicited by combinations of two drugs at different doses and with different efficacies and cooperativity effects, thus providing a conceptual framework for drug combination therapy., This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 848068. This publication reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains. This work is partially supported by the grants PID2020-119136RB-I00, PID-2021-122954NB-I00, PID2022-137708NB-I00 and the Severo Ochoa and María de Maeztu Programs for Centers and Units of Excellence in R&D (CEX2020-001084-M) funded by MCIN/AEI/10.13039/501100011033 and by ERDF “A way of making Europe”, and by the AGAUR grant 2021-SGR-01039. AJO is funded by FPI fellowship (PRE2021-100772) associated to PID2020-119136RB-I00 grant., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Presence of blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafel
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Clàudia
  • Zapata-Tona, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió-Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona, Reinald
  • Maldonado, Rafael, 1961-
  • Fernández Real, Jose M.
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor's Blastocystis subtypes led to altered recipient's mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Claudia
  • Zapata, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové Font, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model

  • Cajiao-Manrique, María Del Mar
  • Casadó-Anguera, Verònica
  • García Blanco, Alejandra
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Background: Cannabis addiction is a chronically relapsing disorder lacking effective treatment. Regular cannabis consumption typically begins during adolescence, and this early cannabinoid exposure may increase the risk for drug addiction in adulthood. Objective: This study investigates the development of cannabis addiction-like behavior in adult mice after adolescent exposure to the main psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC). Methods: Adolescent male mice were exposed to 5 mg/kg of THC from postnatal days 37 to 57. Operant self-administration sessions of WIN 55,212-2 (12.5 μg/kg/infusion) were conducted for 10 days. Mice were tested for three addiction-like criteria (persistence of response, motivation, and compulsivity), two parameters related to craving (resistance to extinction and drug-seeking behavior), and two phenotypic vulnerability traits related to substance use disorders (impulsivity and reward sensitivity). Additionally, qPCR assays were performed to detect differentially expressed genes in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), dorsal striatum, and hippocampus (HPC) of "addicted" and "non-addicted" mice. Results: Adolescent THC exposure did not modify WIN 55,212-2 reinforcement nor the development of cannabis addiction-like behavior. Inversely, THC pre-exposed mice displayed impulsive-like behavior in adulthood, which was more pronounced in mice that developed the addiction-like criteria. Moreover, downregulated drd2 and adora2a gene expression in NAc and HPC was revealed in THC pre-exposed mice, as well as a downregulation of drd2 expression in mPFC of vehicle pre-treated mice that developed addiction-like behaviors. Discussion: These findings suggest that adolescent THC exposure may promote impulsivity-like behavior in adulthood, associated with downregulated drd2 and adora2a expression in NAc and HPC., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, R D21/0009/0019) to RM, the “Generalitat de Catalunya, AGAUR” (2017 SGR-669) to RM, the “ICREA-Acadèmia” (2020) to RM, the “European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099 and QSPain Relief, H2020-SC1-2019-2-RTD-848068) to RM, the Spanish “La Caixa” Foundation under the project code LCF/PR/HR22/52420017 to RM, the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM, the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD-2021I076 to RM and PNSD-2019I006 to EM-G), and Ministerio de Ciencia e Innovación (ERA-NET NEURON) PCI2021-122073-2A to EM-G. MC-M acknowledged the Generalitat de Catalunya and the AGAUR for a “FI-SDUR” scholarship (EMC/3345/2020). AG-B acknowledged the Generalitat de Catalunya and the AGAUR for the “FI” scholarship (FI_B00337_2020). VC-A acknowledged the Spanish MCIN/AEI/10.13039/501100011033 for a “Juan de la Cierva” fellowship (FJC2019-041020-I).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

miRNA signatures associated with vulnerability to food addiction in mice and humans

  • García Blanco, Alejandra
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernández-Castillo, Noèlia
  • Pineda-Cirera, Laura
  • Mayneris Perxachs, Jordi
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
Food addiction is characterized by a loss of behavioral control over food intake and is associated with obesity and other eating disorders. The mechanisms underlying this behavioral disorder are largely unknown. We aimed to investigate the changes in miRNA expression promoted by food addiction in animals and humans and their involvement in the mechanisms underlying the behavioral hallmarks of this disorder. We found sharp similitudes between miRNA signatures in the medial prefrontal cortex (mPFC) of our animal cohort and circulating miRNA levels in our human cohort, which allowed us to identify several miRNAs of potential interest in the development of this disorder. Tough decoy (TuD) inhibition of miRNA-29c-3p in the mouse mPFC promoted persistence of the response and enhanced vulnerability to developing food addiction, whereas miRNA-665-3p inhibition promoted compulsion-like behavior and also enhanced food addiction vulnerability. In contrast, we found that miRNA-137-3p inhibition in the mPFC did not lead to the development of food addiction. Therefore, miRNA-29c-3p and miRNA-665-3p could be acting as protective factors with regard to food addiction. We believe the elucidation of these epigenetic mechanisms will lead to advances toward identifying innovative biomarkers and possible future interventions for food addiction and related disorders based on the strategies now available to modify miRNA activity and expression., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to RM; SAF2015-68341-R, RTI2018-100968-B-100, and PID2021-1277760B-100, to BC; and SAF2017-84060-R-AEI/FEDER-UE, to LD); the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to RM; 2017 SGR-734, to JMFR; 2017-SGR-738, to BC); the “ICREA-Acadèmia” (2020, to RM, 2021, to BC, and 2022, to JMFR); the “European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068, to RM; CoCA, H2020-667302, and Eat2beNICE, H2020-728018, to BC); the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020, to RM; FIS PI15/01934, PI18/01022, PI21/01361, to JMFR); the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to RM; PNSD-2019I006, to EMG; PNSD-2017I050, to BC; PNSD-2020I042, to NFC); the “Fundació La Marató-TV3” (2016/20-30, to EMG); the European Regional Development Fund (project no. 01.2.2-LMT-K-718-03-0099) under a grant agreement with the Research Council of Lithuania (LMTLT), to AB; and the Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020)
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors

  • Renault de Barros, Pedro Victor|||0000-0002-5649-3057
  • Giraldo, Jesús|||0000-0001-7082-4695
G protein-coupled Receptors (GPCRs) play a central role in many physiological processes and, consequently, constitute important drug targets. In particular, the search for allosteric drugs has recently drawn attention, since they could be more selective and lead to fewer side effects. Accordingly, computational tools have been used to estimate the druggability of allosteric sites in these receptors. In spite of many successful results, the problem is still challenging, particularly the prediction of hydrophobic sites in the interface between the protein and the membrane. In this work, we propose a complementary approach, based on dynamical correlations. Our basic hypothesis was that allosteric sites are strongly coupled to regions of the receptor that undergo important conformational changes upon activation. Therefore, using ensembles of experimental structures, normal mode analysis and molecular dynamics simulations we calculated correlations between internal fluctuations of different sites and a collective variable describing the activation state of the receptor. Then, we ranked the sites based on the strength of their coupling to the collective dynamics. In the β2 adrenergic (β2AR), glucagon (GCGR) and M2 muscarinic receptors, this procedure allowed us to correctly identify known allosteric sites, suggesting it has predictive value. Our results indicate that this dynamics-based approach can be a complementary tool to the existing toolbox to characterize allosteric sites in GPCRs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor, Morphine and Fentanyl Elicit Different Activation Patterns

  • Ricarte, Adrián
  • Dalton, James A. R.|||0000-0002-5279-4581
  • Giraldo, Jesús|||0000-0001-7082-4695
Over the past two decades, the opioid epidemic in the United States and Canada has evidenced the need for a better understanding of the molecular mechanisms of medications used to fight pain. Morphine and fentanyl are widely used in opiate-mediated analgesia for the treatment of chronic pain. These compounds target the μ-opioid receptor (MOR), a class A G protein-coupled receptor (GPCR). In light of described higher efficacy of fentanyl with respect to morphine, we have performed independent μs-length unbiased molecular dynamics (MD) simulations of MOR complexes with each of these ligands, including the MOR antagonist naltrexone as a negative control. Consequently, MD simulations totaling 58 μs have been conducted to elucidate at the atomic level ligand-specific receptor activity and signal transmission in the MOR. In particular, we have identified stable binding poses of morphine and fentanyl, which interact differently with the MOR. Different ligand-receptor interaction landscapes directly induce sidechain conformational changes of orthosteric pocket residues: Asp1493.32, Tyr1503.33, Gln1262.60, and Lys2355.39. The induced conformations determine Asp1493.32-Tyr3287.43 sidechain-sidechain interactions and Trp2956.48-Ala2425.46 sidechain-backbone H-bond formations, as well as Met1533.36 conformational changes. In addition to differences in ligand binding, different intracellular receptor conformational changes are observed as morphine preferentially activates transmembrane (TM) helices: TM3 and TM5, while fentanyl preferentially activates TM6 and TM7. As conformational changes in TM6 and TM7 are widely described as being the most crucial aspect in GPCR activation, this may contribute to the greater efficacy of fentanyl over morphine. These computationally observed functional differences between fentanyl and morphine may provide new avenues for the design of safer but not weaker opioid drugs because it is desirable to increase the safety of medicines without sacrificing their efficacy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Statistics for the analysis of molecular dynamics simulations, providing P values for agonist-dependent GPCR activation

  • Bruzzese, Agustín
  • Dalton, James A. R.|||0000-0002-5279-4581
  • Giraldo, Jesús|||0000-0001-7082-4695
Molecular dynamics (MD) is the common computational technique for assessing efficacy of GPCR-bound ligands. Agonist efficacy measures the capability of the ligand-bound receptor of reaching the active state in comparison with the free receptor. In this respect, agonists, neutral antagonists and inverse agonists can be considered. A collection of MD simulations of both the ligand-bound and the free receptor are needed to provide reliable conclusions. Variability in the trajectories needs quantification and proper statistical tools for meaningful and non-subjective conclusions. Multiple-factor (time, ligand, lipid) ANOVA with repeated measurements on the time factor is proposed as a suitable statistical method for the analysis of agonist-dependent GPCR activation MD simulations. Inclusion of time factor in the ANOVA model is consistent with the time-dependent nature of MD. Ligand and lipid factors measure agonist and lipid influence on receptor activation. Previously reported MD simulations of adenosine A2a receptor (A2aR) are reanalyzed with this statistical method. TM6-TM3 and TM7-TM3 distances are selected as dependent variables in the ANOVA model. The ligand factor includes the presence or absence of adenosine whereas the lipid factor considers DOPC or DOPG lipids. Statistical analysis of MD simulations shows the efficacy of adenosine and the effect of the membrane lipid composition. Subsequent application of the statistical methodology to NECA A2aR agonist, with resulting P values in consistency with its pharmacological profile, suggests that the method is useful for ligand comparison and potentially for dynamic structure-based virtual screening.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evaluating Allosteric Perturbations in Cannabinoid Receptor 1 by In Silico Single-Point Mutation

  • Díaz Sanzo, Óscar|||0000-0002-8374-1693
  • Renault de Barros, Pedro Victor|||0000-0002-5649-3057
  • Giraldo, Jesús|||0000-0001-7082-4695
Cannabinoid receptor 1 (CB1) is a promising drug target involved in many physiological processes. Using atomistic molecular dynamics (MD) simulations, we examined the structural effect of F237L mutation on CB1, a mutation that has qualitatively similar effects to allosteric ligand ORG27569 binding. This mutation showed a global effect on CB1 conformations. Among the observed effects, TM6 outward movement and the conformational change of the NPxxY motif upon receptor activation by CB1 agonist CP55940 were hindered compared to wt CB1. Within the orthosteric binding site, CP55940 interactions with CB1 were altered. Our results revealed that allosteric perturbations introduced by the mutation had a global impact on receptor conformations, suggesting that the mutation site is a key region for allosteric modulation in CB1.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A male mouse model of WIN 55,212-2 self-administration to study cannabinoid addiction

  • Cajiao-Manrique, María del Mar
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Martín-García, Elena|||0000-0002-4487-3028
We have established for the first time a mouse model of cannabinoid addiction using WIN 55,212-2 intravenous self-administration (0.0125 mg/kg/infusion) in C57Bl/6J mice. This model allows to evaluate the addiction criteria by grouping them into 1) persistence of response during a period of non-availability of the drug, 2) motivation for WIN 55,212-2 with a progressive ratio, and 3) compulsivity when the reward is associated with a punishment such as an electric foot-shock, in agreement with the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5). This model also allows to measure two parameters that have been related with the DSM-5 diagnostic criteria of craving, resistance to extinction and reinstatement, and two phenotypic traits suggested as predisposing factors, impulsivity and sensitivity to reward. We found that 35.6% of mice developed the criteria of cannabinoid addiction, allowing to differentiate between resilient and vulnerable mice. Therefore, we have established a novel and reliable model to study the neurobiological correlates underlying the resilience or vulnerability to develop cannabinoid addiction. This model included the chemogenetic inhibition of neuronal activity in the medial prefrontal cortex to the nucleus accumbens pathway to assess the neurobiological substrate of cannabinoid addiction. This model will shed light on the neurobiological substrate underlying cannabinoid addiction.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model

  • Cajiao-Manrique, María del Mar
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • García-Blanco, Alejandra
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Martín-García, Elena|||0000-0002-4487-3028
Cannabis addiction is a chronically relapsing disorder lacking effective treatment. Regular cannabis consumption typically begins during adolescence, and this early cannabinoid exposure may increase the risk for drug addiction in adulthood. This study investigates the development of cannabis addiction-like behavior in adult mice after adolescent exposure to the main psychoactive component of cannabis, Δ 9 -tetrahydrocannabinol (THC). Adolescent male mice were exposed to 5 mg/kg of THC from postnatal days 37 to 57. Operant self-administration sessions of WIN 55,212-2 (12.5 μg/kg/infusion) were conducted for 10 days. Mice were tested for three addiction-like criteria (persistence of response, motivation, and compulsivity), two parameters related to craving (resistance to extinction and drug-seeking behavior), and two phenotypic vulnerability traits related to substance use disorders (impulsivity and reward sensitivity). Additionally, qPCR assays were performed to detect differentially expressed genes in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), dorsal striatum, and hippocampus (HPC) of "addicted" and "non-addicted" mice. Adolescent THC exposure did not modify WIN 55,212-2 reinforcement nor the development of cannabis addiction-like behavior. Inversely, THC pre-exposed mice displayed impulsive-like behavior in adulthood, which was more pronounced in mice that developed the addiction-like criteria. Moreover, downregulated drd2 and adora2a gene expression in NAc and HPC was revealed in THC pre-exposed mice, as well as a downregulation of drd2 expression in mPFC of vehicle pre-treated mice that developed addiction-like behaviors. These findings suggest that adolescent THC exposure may promote impulsivity-like behavior in adulthood, associated with downregulated drd2 and adora2a expression in NAc and HPC.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Time-dependent ligand-receptor binding kinetics and functionality in a heterodimeric receptor model

  • Ortiz, Antonio J.
  • Martín, Víctor
  • Romero i Sànchez, David|||0000-0002-2881-268X
  • Guillamon, Antoni|||0000-0001-8268-4503
  • Giraldo, Jesús|||0000-0001-7082-4695
GPCRs heteromerize both in CNS and non-CNS regions. The cell uses receptor heteromerization to modulate receptor functionality and to provide fine tuning of receptor signaling. In order for pharmacologists to explore these mechanisms for therapeutic purposes, quantitative receptor models are needed. We have developed a time-dependent model of the binding kinetics and functionality of a preformed heterodimeric receptor involving two drugs. Two cases were considered: both or only one of the drugs are in excess with respect to the total concentration of the receptor. The latter case can be applied to those situations in which a drug causes unwanted side effects that need to be reduced by decreasing its concentration. The required efficacy can be maintained by the allosteric effects mutually exerted by the two drugs in the two-drug combination system. We discuss this concept assuming that the drug causing unwanted side effects is an opioid and that analgesia is the therapeutic effect. As additional points, allosteric modulation by endogenous compounds and synthetic bivalent ligands was included in the study. Receptor heteromerization offers a mechanistic understanding and quantification of the pharmacological effects elicited by combinations of two drugs at different doses and with different efficacies and cooperativity effects, thus providing a conceptual framework for drug combination therapy.